A heartburn episode can be one of the most uncomfortable and unpleasant instances a person can experience.
However, treating it is very easy. One can buy over-the-counter medication that they can use to experience instant relief.
Yet, authorities have found out that a few of the most popular anti-heartburn medications available in the market to be carcinogenic and ordered their recall immediately.
In 2019, authorities all over the world had ordered the recall of a handful of popular ranitidine-based heartburn medication due to fears that it contained high levels of NDMA.
NDMA or N-nitrosodimethylamine is a chemical substance listed by health authorities as a probable human carcinogen.
The findings triggered a series of recall orders worldwide, with countries enforcing varying degrees of recalls.
Australian authorities, on their part, have warned consumers of the effects of NDMA exposure to the body.
The United States only enforced a voluntary recall for ranitidine-based heartburn medications, while Canada took a much tougher stance.
The country’s Health Canada agency ordered a mandatory recall of the possibly carcinogenic medicine – inadvertently causing a shortage of other heartburn medication alternatives during the early days when the news broke out.
Canadian authorities have ordered more than ten companies to recall their ranitidine-based heartburn medications in circulation in the country.
- Apotex Inc.
- Dominion Pharmacal
- Laboratoire Riva Inc.
- Pharmascience Inc.
- Pro Doc Limitée
- Ranbaxy Pharmaceuticals Canada Inc.
- Sandoz Canada
- Sanis Health Inc.
- Sanofi Consumer Health Inc.
- Sivem Pharmaceuticals ULC
- Teva Canada Limited
- Vita Health Products Inc.
This launched a wave of class action lawsuits filed in several Canadian courts by aggrieved customers who have bought and used ranitidine-based heartburn medication products to alleviate their discomfort.
In the U.S., though, it is a different story. Since authorities have only ordered a voluntary recall, most products are still being sold and distributed in the market as we speak.
Popular brands of such ranitidine-based heartburn medications include Sanofi’s Zantac, which can still be bought in stores nationwide.
Classic symptoms of ranitidine exposure are rare and not severe; however, authorities have stressed that people should still look out for them. Symptoms range from nausea to various gastrointestinal discomforts such as constipation, diarrhea, etc.
If you are a frequent user of Zantac and other ranitidine-based heartburn medicine, you can be eligible to file a complaint against pharmaceutical companies.
Editor’s Note on Possible Lawsuit Over Zantac & Other Heartburn Medicines Recall:
This article’s goal is to give you information about the worldwide recall order involving several heartburn products which authorities found out to contain high amounts of cancer-causing N-nitrosodimethylamine (NDMA). A lawsuit is possible against the companies effected.
Case Name & No.: Zantac & Other Heartburn Medicines Recall
Jurisdiction: Various countries worldwide
Products/Services Involved: Heartburn medications
Allegation(s): Several heartburn medications contain unacceptable levels of NDMA (N-nitrosodimethylamine) which authorities have suspected to cause cancer to humans.
What are your thoughts on this piece? Please send us a message by clicking the ‘Contact Us’ button below! We’d love to hear back from you.
Suggested Article: CVS Baby Pain & Fever Medicine Possible Lawsuit.